FIELD: pharmacology.
SUBSTANCE: means is a complex of flavonoids isolated from the aerial part of the Lychnis chalcedonica L. plant by 5-fold extraction with 70% ethanol at a feedstock:extractant ratio of 1:22.5, followed by extraction with n-butanol, purification of the precipitate from the aqueous fraction by ethyl acetate-ethanol solvent systems at ratios of 5:1 and 3:1.
EFFECT: marked anti-inflammatory and analgesic effect.
2 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS WITH GASTROPROTECTIVE ACTIVITY | 2016 |
|
RU2629090C1 |
MEDICINAL PRODUCT WITH ANTIHYPOXIC EFFECT | 2023 |
|
RU2813662C1 |
AGENT WITH WOUND-HEALING EFFECT | 2022 |
|
RU2788469C1 |
ANALGESIC (VERSIONS) | 2006 |
|
RU2367461C2 |
4-(2-ETOXYACETYL)-2,6,8,10,12-PENTAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO [5,5,0,0,0] DODECANE AS ANALGETIC AND METHOD OF ITS OBTAINING | 2023 |
|
RU2808905C1 |
AGENT ELICITING ANTI-INFLAMMATORY AND ANALGESIC EFFECT | 2004 |
|
RU2260441C1 |
METHOD OF PRODUCING ANTIFUNGAL AGENT OF HERBAL RAW MATERIAL | 2010 |
|
RU2435602C1 |
4,10-DI(ETOXYACETIL)-2,6,8,12-TETRAACETIL-2,4,6,8,10,12-HEXAAZATETRACYCLO [5,5,0,0,0]DODECANE AS ANTI-INFLAMMATORY | 2022 |
|
RU2798994C1 |
4-(3,4-DIBROMOTHIOPHENE CARBONYL)-10-(2-ETHOXYACETYL)-2,6,8,12-TETRAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO[5,5,0,0,0]DODECANE AS AN ANALGESIC AGENT AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2786231C1 |
4-(3,4-DIBROMOTHYOPHENE CARBONYL)-2,6,8,10,12-PENTAACETYL-2,4,6,8,10,12 HEXAAZAISOWURTZITANE AS AN ANALGESIC AGENT AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2769523C1 |
Authors
Dates
2017-08-30—Published
2016-10-03—Filed